CC0 PUBLIC RECORD GRAPH Every score & timeline item links directly to its underlying U.S. FDA record (openFDA, ORA FOIA Reading Room, DECRS & OASIS).
FG
GMPGraphv2.0
Global FDA Facility Graph & Co-Packer Intelligence
21 CFR CLAUSE ENCYCLOPEDIA ยท 40 ENRICHED CITATION HUBS (1,620 OFFICIAL TEMPLATES)

FDA 21 CFR Citation Encyclopedia & Free SOP Clauses

Every federal cGMP clause cited on FDA Form 483s translated into plain English โ€” with historical citation frequency, inspector red-flag triggers, CAPA remediation playbooks, and copy-paste SOP templates.

๐Ÿ›ก๏ธ Audit Your SOPs Against All 1,620 Clauses โ†’
21 CFR 312.60 Bioresearch Monitoring
Rank #1 ยท 80 Annual FDA Citations
21 CFR 312.60: FD-1572, protocol compliance

Failure to thoroughly investigate unexplained batch discrepancies, Out-of-Specification lab results, or consumer complaints/adverse events and document root-cause Corrective and Preventive Actions (CAPA).

Official Inspector Observation Language: "An investigation was not conducted in accordance with the [signed statement of investigator] [investigational plan]. Specifically, ***..."
Theme: CAPA, Out-of-Specification (OOS) & Complaint Investigations